002275.SZ
桂林三金
SZSE · Healthcare · C 制造业 · CN
CNY 12.57
−4.99%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.1B | 2.0B | 2.2B | 2.2B | 2.0B |
| Cost of Revenue | 479.8M | 490.4M | 583.3M | 586.4M | 568.8M |
| Gross Profit | 1.6B | 1.6B | 1.6B | 1.6B | 1.4B |
| Operating Expenses | |||||
| R&D Expense | 174.9M | 160.0M | 173.3M | 158.1M | 217.0M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 139.0M | 144.6M | 151.4M | 202.8M | 274.3M |
| Selling & Marketing Expense | 676.5M | 673.2M | 736.9M | 717.9M | 538.3M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.0B | 1.0B | 1.1B | 1.1B | 1.1B |
| Cost and Expenses | 1.5B | 1.5B | 1.7B | 1.7B | 1.6B |
| Operating Income (EBIT) | 561.2M | 539.1M | 644.8M | 518.3M | 446.8M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 559.3M | 536.9M | 643.9M | 518.3M | 446.2M |
| Income Tax Expense | 106.6M | 103.8M | 122.4M | 97.0M | 116.7M |
| Bottom Line | |||||
| Net Income | 452.7M | 433.1M | 521.5M | 421.3M | 329.5M |
| Earnings from Cont. Ops | 452.7M | 433.1M | 521.5M | 421.3M | 329.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 452.7M | 433.1M | 521.5M | 421.3M | 329.5M |
| Per Share | |||||
| Basic EPS | CN¥0.77 | CN¥0.74 | CN¥0.89 | CN¥0.72 | CN¥0.56 |
| Diluted EPS | CN¥0.77 | CN¥0.74 | CN¥0.89 | CN¥0.72 | CN¥0.56 |
| Revenue Per Share | CN¥3.55 | CN¥3.50 | CN¥3.74 | CN¥3.71 | CN¥3.33 |
| Shares | |||||
| Basic Shares Outstanding | 592.2M | 585.3M | 586.0M | 585.1M | 588.4M |
| Diluted Shares Outstanding | 592.2M | 585.3M | 586.0M | 585.1M | 588.4M |
| Profitability Metrics | |||||
| EBITDA | — | 634.4M | 755.8M | 643.0M | 552.5M |
| D&A | — | 95.3M | 111.0M | 124.7M | 105.8M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026